Kerusso Capital Management LLC

Position in BMY — Bristol Myers Squibb Co

CIK 2029597 Winston Salem, NC

Position in BMY

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$4,482,720

+$659,223 QoQ

Shares Held

77,798

+23.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

1.63%

of 13F equity value

Holder Rank

#575

of 2,506 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 71% Shared 0% None 29%

Healthcare · as of Jun 30, 2026

Kerusso Capital Management LLC holds $25,879,752 across 6 Drug Manufacturers - General names. BMY ranks #4 (17.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	50,385	$6,365,640
2	ABBV	AbbVie Inc.	22,511	$5,664,668
3	AMGN	Amgen Inc	15,282	$5,533,917
4	BMY	Bristol Myers Squibb Co This page	77,798	$4,482,720
5	MRK	Merck & Co., Inc.	16,017	$2,058,184
6	PFE	Pfizer Inc	73,697	$1,774,623

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,482,720	77,798	+23.4%	Shares	Sole	2026-07-31
2026-03-31	$3,823,497	63,042	-6.6%	Shares	Sole	2026-05-14
2025-12-31	$3,642,406	67,527	+23.8%	Shares	Sole	2026-01-28
2025-09-30	$2,459,708	54,539	+206.5%	Shares	Sole	2025-10-28
2025-06-30	$823,823	17,797	-63.3%	Shares	Sole	2025-08-04
2025-03-31	$2,955,148	48,453	+2.6%	Shares	Sole	2025-05-12
2024-12-31	$2,670,480	47,215	+0.2%	Shares	Sole	2025-01-31
2024-09-30	$2,437,523	47,111	+6.5%	Shares	Sole	2024-11-01
2024-06-30	$1,837,619	44,248	—	Shares	Sole	2024-08-06
No filing history on record for this holder in this stock.